Umer Sajid
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Umer Sajid has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Maheen Sheraz
Department of Medicine, Continental Medical College, Lahore, Pakistan
7 shared publications - Minahil Zaheer
HBS Medical and Dental College, Islamabad, Pakistan
2 shared publications - Muneeba Umar
HBS Medical and Dental College, Islamabad, Pakistan
2 shared publications Sheharyar Saleem
2 shared publications- Bilal Aslam
University of Lahore Lahore Pakistan
1 shared publication - Fatima Sajjad
Department of Medicine, Khyber Medical College, Peshawar, Pakistan
1 shared publication
Latest Publications
- Open Access
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Coexisting Hepatic and Renal Dysfunction During Pulmonary Tuberculosis Treatment: A Case Report
Anti‐tuberculosis therapy may rarely cause concurrent liver and kidney injury, with ANCA positivity suggesting immune involvement. This case highlights the importance of early recognition, treatment modification, and multidisciplinary care to prevent complications and ensure effective tuberculosis management.
- 10 May 2026
- Published by Wiley in Clinical Case Reports
- Vol. 14 (5)
Open AccessCoexisting Hepatic and Renal Dysfunction During Pulmonary Tuberculosis Treatment: A Case Report
Anti‐tuberculosis therapy may rarely cause concurrent liver and kidney injury, with ANCA positivity suggesting immune involvement. This case highlights the importance of early recognition, treatment modification, and multidisciplinary care to prevent complications and ensure effective tuberculosis management.
- 22 April 2026
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 38 (4) , 344
Development and Validation of a Health Belief Model–Based Health Education Toolkit in Measles Vaccination for Parents in Malaysia
- 22 April 2026
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 38 (4) , 344
Development and Validation of a Health Belief Model–Based Health Education Toolkit in Measles Vaccination for Parents in Malaysia
- Open Access
- 27 March 2026
- Published by S. Karger AG in Endocrinology Insights
- p. 1-10
Cardiovascular Disease Mortality in Patients with Hypothyroidism: A 22-Year National Analysis of US Trends and Disparities
Introduction: Hypothyroidism is a prevalent endocrine disorder that has been linked to adverse cardiovascular outcomes. However, national-level trends and disparities in cardiovascular disease (CVD)-related mortality among individuals with hypothyroidism remain incompletely characterized. This study aimed to evaluate long-term temporal trends and demographic disparities in CVD mortality among US adults with hypothyroidism. Methods: We conducted a retrospective population-based analysis using death certificate data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database from 1999 to 2020. Adults aged ≥25 years with hypothyroidism were identified using ICD-10 codes E02–E03, with CVD-related deaths defined by ICD-10 codes I00–I99. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using the 2000 US standard population. Temporal trends were analyzed using joinpoint regression to estimate annual percent change (APC), and subgroup analyses were performed by sex, race/ethnicity, age group, urban-rural status, and place of death. Results: Between 1999 and 2020, 382,906 CVD-related deaths were associated with hypothyroidism, corresponding to an overall AAMR of 8.00 per 100,000. Mortality rates increased steadily over the study period, peaking at 10.12 per 100,000 in 2020, with the most pronounced rise occurring between 2018 and 2020 (APC 14.01%). Women accounted for nearly three times as many deaths as men, although mortality rates increased more rapidly among men. Non-Hispanic white individuals exhibited the highest absolute mortality burden, while Hispanic populations experienced the fastest growth in mortality rates. The largest relative increases were observed among adults aged 35–44 and 45–54 years. Mortality rates were consistently higher in rural compared with urban areas, and the majority of deaths occurred in long-term care facilities. Conclusion: CVD-related mortality among US adults with hypothyroidism has risen substantially over the past two decades, with marked disparities across sex, age, race/ethnicity, and geographic location. These findings highlight the need for targeted cardiovascular risk assessment, early detection of hypothyroidism, and integrated management strategies, particularly in high-risk and underserved populations, to mitigate rising mortality and reduce health inequities.
- 27 March 2026
- Published by S. Karger AG in Endocrinology Insights
- p. 1-10
Open AccessCardiovascular Disease Mortality in Patients with Hypothyroidism: A 22-Year National Analysis of US Trends and Disparities
Introduction: Hypothyroidism is a prevalent endocrine disorder that has been linked to adverse cardiovascular outcomes. However, national-level trends and disparities in cardiovascular disease (CVD)-related mortality among individuals with hypothyroidism remain incompletely characterized. This study aimed to evaluate long-term temporal trends and demographic disparities in CVD mortality among US adults with hypothyroidism. Methods: We conducted a retrospective population-based analysis using death certificate data from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) database from 1999 to 2020. Adults aged ≥25 years with hypothyroidism were identified using ICD-10 codes E02–E03, with CVD-related deaths defined by ICD-10 codes I00–I99. Age-adjusted mortality rates (AAMRs) per 100,000 population were calculated using the 2000 US standard population. Temporal trends were analyzed using joinpoint regression to estimate annual percent change (APC), and subgroup analyses were performed by sex, race/ethnicity, age group, urban-rural status, and place of death. Results: Between 1999 and 2020, 382,906 CVD-related deaths were associated with hypothyroidism, corresponding to an overall AAMR of 8.00 per 100,000. Mortality rates increased steadily over the study period, peaking at 10.12 per 100,000 in 2020, with the most pronounced rise occurring between 2018 and 2020 (APC 14.01%). Women accounted for nearly three times as many deaths as men, although mortality rates increased more rapidly among men. Non-Hispanic white individuals exhibited the highest absolute mortality burden, while Hispanic populations experienced the fastest growth in mortality rates. The largest relative increases were observed among adults aged 35–44 and 45–54 years. Mortality rates were consistently higher in rural compared with urban areas, and the majority of deaths occurred in long-term care facilities. Conclusion: CVD-related mortality among US adults with hypothyroidism has risen substantially over the past two decades, with marked disparities across sex, age, race/ethnicity, and geographic location. These findings highlight the need for targeted cardiovascular risk assessment, early detection of hypothyroidism, and integrated management strategies, particularly in high-risk and underserved populations, to mitigate rising mortality and reduce health inequities.
- 12 September 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (12) , 2504
Liver transplantation in people living with HIV – methodological considerations and future directions
- 12 September 2025
- Published by Elsevier in Digestive and Liver Disease
- Vol. 57 (12) , 2504
Liver transplantation in people living with HIV – methodological considerations and future directions
- Open Access
- 5 September 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (2) , 1355-1356
Letter to the Editor: Comment on “Gastrointestinal Management Enhanced Recovery After Surgery Protocol Improves Postoperative Recovery in Patients Undergoing Posterior Lumbar Interbody Fusion”
- 5 September 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (2) , 1355-1356
Open AccessLetter to the Editor: Comment on “Gastrointestinal Management Enhanced Recovery After Surgery Protocol Improves Postoperative Recovery in Patients Undergoing Posterior Lumbar Interbody Fusion”
- 23 July 2025
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 37 (8) , 738-739
Comment on “Association Between Systemic Health Indicators and Periodontal Disease in Korean Adults: A Nationwide Cross-Sectional Study”
- 23 July 2025
- Published by SAGE Publications in Asia Pacific Journal of Public Health
- Vol. 37 (8) , 738-739
Comment on “Association Between Systemic Health Indicators and Periodontal Disease in Korean Adults: A Nationwide Cross-Sectional Study”
- Open Access
- 10 July 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1) , 827
Comment on AO Spine Knowledge Forums Promote Collaboration and Elevate the Impact of Research: Bibliometric Analysis
- 10 July 2025
- Published by SAGE Publications in Global Spine Journal
- Vol. 16 (1) , 827
Open AccessComment on AO Spine Knowledge Forums Promote Collaboration and Elevate the Impact of Research: Bibliometric Analysis
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (6) , 584-585
Comments on: “Impact of RNF213 Polymorphism in Isolated Intracranial Arterial Steno-Occlusive Disease”
Sajid U, et al. J Clin Neurol. 2025 Sep;21:e46. https://doi.org/10.3988/jcn.2025.0334
- 1 January 2025
- Published by XMLink in Journal of Clinical Neurology
- Vol. 21 (6) , 584-585
Open AccessComments on: “Impact of RNF213 Polymorphism in Isolated Intracranial Arterial Steno-Occlusive Disease”
Sajid U, et al. J Clin Neurol. 2025 Sep;21:e46. https://doi.org/10.3988/jcn.2025.0334